|
|
UNUSUAL CASE |
|
|
|
| Year : 2009 | Volume
: 5
| Issue : 4 | Page : 118-120 |
| |
Adrenal myelolipoma a rare benign tumour managed laparoscopically: Report of two cases
Bandar Al Harthi, Muhammad M Riaz, Amal H Al Khalaf, Mohammad Al Zoum, Wafa Al Shakweer
Department of Surgical Specialties, Breast and Endocrine Division, Riyadh, Saudi Arabia
| Date of Submission | 01-Jun-2009 |
| Date of Acceptance | 06-Nov-2009 |
| Date of Web Publication | 22-Jan-2010 |
Correspondence Address:
Bandar Al Harthi
Department of Surgery, KFMC, Riyadh Po Box 59046, Kingdom of Saudi Arabia 11525
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-9941.59312
Adrenal Myelolipoma is a rare benign neoplasm composed of mature adipose tissue and a variable amount of haemopoietic elements. Most lesions are small and asymptomatic, discovered incidentally during autopsy or on imaging studies performed for other reasons. Two cases of myelolipoma are presented here, where the tumours were hormonally inactive, but presented with abdominal symptoms and were managed by laparoscopic adrenalectomy.
Keywords: Angiomyelolipoma, laparoscopic adrenalectomy, myelolipoma
How to cite this article:
Al Harthi B, Riaz MM, Al Khalaf AH, Al Zoum M, Al Shakweer W. Adrenal myelolipoma a rare benign tumour managed laparoscopically: Report of two cases. J Min Access Surg 2009;5:118-20 |
How to cite this URL:
Al Harthi B, Riaz MM, Al Khalaf AH, Al Zoum M, Al Shakweer W. Adrenal myelolipoma a rare benign tumour managed laparoscopically: Report of two cases. J Min Access Surg [serial online] 2009 [cited 2021 Feb 25];5:118-20. Available from: https://www.journalofmas.com/text.asp?2009/5/4/118/59312 |
| € Introduction | |  |
Myelolipomas are rare, benign tumours, usually found in the adrenal gland, although myelolipomatous foci can be present in other extra-adrenal locations. These tumours were initially described by Giercke in 1905, and 24 years later, Oberling coined the team 'myelolipoma'. They are composed of mature adipocytes and normal haematopoietic tissue. Although they do not represent a hematopoietic source, they contain precursors of white and red blood cells such as megakaryocytes. [1]
The incidence of adrenal myelolipoma is reported as being 0.08 to 0.4% at autopsy. [2] More often than not, the male-to-female ratio is 1:1, however, a study reported a male-to-female ratio of 2:3. [3] With the vast use of non-invasive imaging its incidental detection has become more common, reaching up to 7% of the adrenal masses. [4] Adrenal myelolipoma present as a site of extramedullary haematopoiesis. Although great numbers of incidentally discovered lesions are small and asymptomatic, reports are not infrequent for cases of large symptomatic lesions. The most well-recognised complication of adrenal myelolipoma is spontaneous retroperitoneal haemorrhage. [5],[6] No potential of malignancy for adrenal myelolipoma has been proved. Symptomatic lesions must be treated, and with the advent of minimal invasive surgery, laparoscopic adrenalectomy has shown a considerable decrease in surgically derived morbidity as well as hospital stay and convalescence. [7]
We report two cases of symptomatic myelolipoma where diagnosis was made on the basis of radiological features and image-guided fine-needle biopsies, and were treated with laparoscopic adrenalectomy.
| € Case Reports | | |
Case 1
A 53-year-old female presented with complaints of intermittent, dull aching, vague abdominal pain of few months duration. The physical examination was unremarkable. A CT scan revealed a right adrenal mass measuring 6.5 3 5.2 cm. It was labelled as a fat containing mass, raising the possibility of lipoma, fat-rich adrenal adenoma or liposarcoma. The patient was subjected to multiplanar, multisequential magnetic resonance imaging (MRI) of the adrenal glands and pre- and post-gadolinium injections, to further evaluate this mass. The findings of were consistent with myelolipoma [Figure 1]. Laboratory investigations revealed the non-functioning nature of the adrenal mass, such as, urinary adrenaline 3 ug/24 hours (Ref: 27 ug/24 hours), noradrenaline 55 ug/24 hours (ref: 97 ug/24 hours) and Dopamine 454 ug/24 hours (ref: 500 ug/24 hours), in a total volume of 2600 ml of urine. Plasma biochemistry showed levels of adrenaline as 20 ug/L (ref: 84 ng/l), noradrenaline 163 ng/L (ref: 420 ng/l) and Dopamine 20 ng/L (ref: 85 ng/l). Urinary Vanillyl mandelic acid (VMA) was 3.0 mg/24 hours (ref: 6.8 mg/24 hours). Free Cortisol, metanephrines and normetanephrines were also within normal limits. CT-guided fine-needle aspiration cytology confirmed the diagnosis and the patient underwent laparoscopic right adrenalectomy with a smooth, postoperative recovery. Histopathology revealed myelolipoma.
Case 2
A 43-year-old female, known to have hypertension, presented with right loin pain, occasional palpitations and increased flushing, for the last 20 months. The physical examination was unremarkable and an ultrasound (US) of the abdomen revealed a right adrenal mass lesion. Blood and urine investigations showed the non-functioning nature of the adrenal mass. A contrast CT revealed a non-enhancing mass lesion, arising from the lateral limb of the right adrenal gland, measuring 7 3 5.4 cm, consistent with fat, and further characterisation by a multiplanar MRI with a gadolinium injection showed a 7.2 3 5.7 3 6.1 cm mass arising from the lateral limb of the right adrenal gland, composed mainly of fat. Laboratory investigations revealed the non-functioning nature of the mass, such as, adrenaline 20 ng/L, noradrenaline 217 ng/L and plasma cortisol 53.81 nmol/l. Free cortisol in 24 hours collected urine (total volume 1700 ml) was 187.68 nmol/L. Urinary levels of adrenaline were 20 ug/24 hours (ref: 27 ug/24 hours), noradrenaline 24 ug/24 hours (ref: 97 ug/24 hours), Dopamine 377 ug/24 hours (ref: 500 ug/24 hours) and urinary VMA was 2.2 mg/24 hours (ref: 6.8 mg/24 hours). As there was no evidence of functioning pheochromocytoma, she was diagnosed as having essential hypertension and managed with medications and no metaiodobenzylguanidine (MIBG) scan was performed. A CT-guided fine-needle aspiration cytology confirmed the diagnosis of myelolipoma. Keeping in view the large size of the mass lesion and duration of symptoms, she underwent laparoscopic right adrenalectomy. The postoperative course was uneventful.
Histopathology revealed myelolipoma with extramedullary haematopoiesis measuring 8.5 3 5 3 5 cm and weighing 80 grams [Figure 2].
| € Discussion | | |
Myelolipomas are small, asymptomatic and non-functional in nature. The benign nature of these lesions has been established. Nevertheless, it remains unclear how this tumour actually develops. Although the pathogenesis of myelolipomas remains speculative, the most widely accepted theory is the existence of metaplasia of reticuloendothelial cells of blood capillaries in the adrenal glands, in response to stimuli, such as, necrosis, infection or stress. [5]
Myelolipomas in our patients were found with other medical conditions, such as, hypertension, diabetes mellitus and obesity. There is no proven link between these conditions and myelolipomas, yet elderly patients undergo imaging studies for other reasons, facilitating incidental diagnosis. Occasionally there are clinical symptoms such as abdominal pain or flank pain as in our patients. Spontaneous retroperitoneal haemorrhage in association with myelolipoma has been described. [6]
Histological examination of a myelolipoma shows adipocytes with interspersed haematopoietic elements, consisting of myeloid and erthyroid precursors, as well as, megakaryocytes. [6] When a suspicious mass is symptomatic or when diagnosis is not clear, surgical exploration becomes necessary. Traditionally the classic approach to this pathology has been open surgery. [6] Ever since its introduction by Gagner in 1992, laparoscopic adrenalectomy has become the standard of care for the treatment of functioning and non-functioning adrenal tumours. Many authors have found a decrease in perioperative morbidity and convalescence after this procedure when compared with open surgery. [7]
We conclude that adrenal myelolipomas are rare tumours. Patients with small, asymptomatic myelolipomas must be monitored clinically for symptoms and routine follow-up imaging studies appear unnecessary for such lesions. Surgical treatment must be reserved for selected patients with large and symptomatic lesions. Occasionally large silent tumours are excised, to prevent the occurrence of a rupture or intra-tumoural haemorrhage.
| € References | | |
| 1. | Kenney PJ, Wagner BJ, Rao P, Heffess CS. Myelolipoma: CT and pathologic features. Radiology 1998;208:87-95.  [PUBMED] [FULLTEXT] |
| 2. | Olsson CA, Kran RJ, Klugo RC, Selikowitz SM. Adrenal myelolipoma. Surgery 1973;73:665-70. |
| 3. | Han M, Burnett A, Fishman EK, Marshall FF. The natural history and treatment of adrenal myelolipoma. J Urol 1997;157:1213-6. |
| 4. | Aso Y, Homma Y. A survey on incidental adrenal tumours in Japan. J Urol 1992;147:1478-81. [PUBMED] [FULLTEXT] |
| 5. | Meaglia JP, Schmidt JD. Natural history of an adrenal myelolipoma. J Urol 1992;147:1089-90. [PUBMED] [FULLTEXT] |
| 6. | Lawler LP, Pickhardt PJ. Giant adrenal myelolipoma presenting with spontaneus hemorrhage: CT, MR and pathology correlation. Ir Med J 2001;94:231. [PUBMED] [FULLTEXT] |
| 7. | Novitsky YW, Czerniach DR, Kercher KW, Perugini RA, Kelly JJ, Litwin DE. Feasibility of laparoscopic adrenalectomy for large adrenal masses. Surg Laparosc Endosc Percutan Tech 2003;13:106-10. [PUBMED] [FULLTEXT] |
[Figure 1], [Figure 2]
| This article has been cited by | | 1 |
A 10-Year Single-Center Experience with Surgical Management of Adrenal Myelolipoma |
|
| Lei Yin,Jingfei Teng,Qiwei Zhou,Yushan Liu,Yacheng Yao,Yi Gao,Xingang Cui,Jizhong Ren,Danfeng Xu | | Journal of Endourology. 2014; 28(2): 252 | | [Pubmed] | [DOI] | | | 2 |
Do giant adrenal myelolipomas behave differently? A clinicopathological comparative study |
|
| Ramakant, P. and Mukha, R. and Cherian, A.J. and Naik, D. and Paul, T.V. and Abraham, D.T. and Paul, M.J. | | World Journal of Endocrine Surgery. 2013; 5(1): 12-15 | | [Pubmed] | | | 3 |
Giant Adrenal Non-functioning Tumor: A Case Report and Review of Literature |
|
| Jain, S. and Gupta, N. and Kumar, R. and Sen, A.K. and Arora, M.P. | | Indian Journal of Surgical Oncology. 2012; 3(1): 30-32 | | [Pubmed] | | | 4 |
Giant adrenal myelolipoma [Mielolipoma suprarrenal gigante] |
|
| Patricio Gac, E. and Patricio Cabané, T. and Eulin Klein, P. and Camila Seymur, M. and Paula Segura, H. | | Revista Chilena de Cirugia. 2012; 64(3): 292-296 | | [Pubmed] | | | 5 |
Diagnosis and treatment of adrenal myelolipoma |
|
| Qu, L.-X. and Li, L.-P. and Wang, X. and Ding, Q. | | Fudan University Journal of Medical Sciences. 2012; 39(3): 297-300 | | [Pubmed] | | | 6 |
Pathophysiology and management aspects of adrenal angiomyolipomas |
|
| Hussain, T. and Al-Hamali, S. | | Annals of the Royal College of Surgeons of England. 2012; 94(4): e224-e226 | | [Pubmed] | | | 7 |
Giant Adrenal Non-functioning Tumor: A Case Report and Review of Literature |
|
| Shubham Jain,Nikhil Gupta,Rajeev Kumar,A. K. Sen,M. P. Arora | | Indian Journal of Surgical Oncology. 2012; 3(1): 30 | | [Pubmed] | [DOI] | | | 8 |
Adrenal myelolipomas composed with adrenal nodular hyperplasia in the same gland |
|
| Babinska, A. and NaĆecz, A. and Swiatkowska-Stodulska, R. and Sworczak, K. | | Polish Journal of Pathology. 2012; 63(1): 45-48 | | [Pubmed] | |
|
|
|
|
|
|
|
|
